Возраст домена | 9 лет |
Дата окончания | Истек срок регистрации |
ИКС | 10 |
Страниц в Google | 1010 |
Страниц в Яндексе | n/a |
Dmoz | Нет |
Яндекс Каталог | Нет |
Alexa Traffic Rank | 17681657 |
Alexa Country | Нет данных |
История изменения показателей | Авторизация |
Идет сбор информации... Обновить
MSF TB Symposium | English
n/a
n/a
UTF-8
31.72 КБ
1 523
13 034 симв.
11 093 симв.
Идет сбор информации... Обновить
Идет сбор информации... Обновить
Внешние ссылки главной страницы ( 6 ) | |
msfaccess.org/content/dr-tb-drugs-under-microscope-4th-editi... | DR-TB Drugs, Under the Microscope |
msfaccess.org/TBmanifesto/ | TB Manifesto |
blogs.msf.org/en/patients/blogs | TB&Me Blog |
tb-symposium.msf.ch/en/ | TB Symposium in Bishkek, Kyrgyzstan |
msf-uzbekistan.org/tb-symposium/en | TB Symposium in Tashkent, Uzbekistan |
msf.org/ | Médecins Sans Frontières - Doctors Without Borders |
Внутренние ссылки главной страницы ( 37 ) | |
/ru/ | по-русски |
/documents/en/agenda_en.pdf | Agenda.pdf |
/documents/en/Inaugural_Session/giorgi_kuchukhidze_TB_epidem... | Introduction |
/documents/en/2_WHO_BENEFITS/new_drugs_implementation_fuad_m... | Where are we at with the implementation of new drugs? by Dr Fuad Mirzayev, Medical Officer of Laboratories, Diagnostics & Drug R... |
/documents/en/2_WHO_BENEFITS/jay_achar_newdrugs.pdf | Where are we at with the implementation of new drugs? by Dr Jay Achar, TB/HIV Programme and Research Implementer, Manson Unit, M... |
/documents/en/2_WHO_BENEFITS/sharonann_lynch_funding_mechani... | Funding mechanisms by Sharonann Lynch, HIV & TB Policy Advisor, Médecins Sans Frontières Access Campaign, Geneva |
/documents/en/2_WHO_BENEFITS/sandrine_cloez_access_to_drtb_d... | Access to DRTB drugs: current situation and challenges by Sandrine Cloez, TB pharmacist, Médecins Sans Frontières International,... |
/documents/en/2_WHO_BENEFITS/francis_varaine_beyond_xdrtb.pd... | Beyond XDR TB - what other patients could benefit from new drugs? by Dr Francis Varaine, TB working group coordinator & endTB le... |
/documents/en/2_WHO_BENEFITS/kris_herboczek_hepatitis_c_and_... | TB and comorbidities: the example of hepatitis C by Dr Krzysztof Herboczek, TB referent, Médecins Sans Frontières, Operational ... |
/documents/en/3_NEXT_STEPS/jay_achar_short_course_regimen_po... | Short-Course Regimens by Dr Jay Achar, TB referent, Médecins Sans Frontières, Operational Center Amsterdam |
/documents/en/3_NEXT_STEPS/lorenzo_guglielmetti_bdq_beyond_2... | Off label use: Bedaquilline beyond 24 weeks by Dr Lorenzo Guglielmetti , Medical doctor, Bligny Hospital, Paris |
/documents/en/3_NEXT_STEPS/jennifer_furin_combination_of_bdq... | Combination of Bedaquilline and Delamanid: from theory to practice by Dr Jennifer Furin, Lecturer at the Department of Global H... |
/documents/en/3_NEXT_STEPS/jennifer_furin_children_under_18.... | Children under 18 year old with Dlm or Bdq by Dr Jennifer Furin, Lecturer at the Department of Global Health & Social Medicine,... |
/documents/en/3_NEXT_STEPS/sylvie_jonckheere_children_treate... | Children under 18 year old with Dlm or Bdq by Dr Sylvie Jonckheere, Project medical referent, Médecins Sans Frontières, India |
/documents/en/3_NEXT_STEPS/ia_urtkmelidze_pediatric_patient_... | Children under 18 year old with Dlm or Bdq by Dr Ia Urtkmelidze, TB Pediatrician, National Center for Tuberculosis and Lung Dise... |
/documents/en/3_NEXT_STEPS/bdq_child_tajikistan_case_report.... | Children under 18 year old with Dlm or Bdq by Dr Alan Adler, Medical Doctor, Médecins Sans Frontières, Tajikistan |
/documents/en/3_NEXT_STEPS/carole_mitnick_endtb.pdf | Clinical trials update by Dr Carole Mitnick, Associate professor at the Department of Global Health & Social Medicine, Harvard ... |
/documents/en/3_NEXT_STEPS/bern_nyang_wa_tb_practecal.pdf | Clinical trials update by Dr Bern-Thomas Nyang’wa, Project Manager and Chief Investigator of TB PRACTECAL, Médecins Sans Frontiè... |
/documents/en/4_IMPLEMENTING_POLICIES/maira_zhaparkulova_tb_... | Treatment of TB amongst migrant populations by Dr Maira Zhaparkulova, Medical coordinator of Ministry of Health, Kazakhstan |
/documents/en/4_IMPLEMENTING_POLICIES/who_policies_fuad_mirz... | WHO policies implementation by Dr Grania Brigden, TB Advisor, Médecins Sans Frontières’ Access Campaign, Geneva |
/documents/en/4_IMPLEMENTING_POLICIES/grania_brigden_who_pol... | New WHO guidelines in the pipeline by Dr Fuad Mirzayev, Medical Officer of Laboratories, Diagnostics & Drug Resistance Unit of ... |
/documents/en/5_IMPROVING_PATIENTS_EXPERIENCE/beverley_strin... | Adherence: where there is hope by Beverly Collin Stringer, Health Policy and Research Advisor, Médecins Sans Frontières UK |
/documents/en/5_IMPROVING_PATIENTS_EXPERIENCE/alena_skrahina... | Counselling: what role in national programs and how to improve patient support by Dr Alena Skrahina, Deputy Director of the Nati... |
/documents/en/5_IMPROVING_PATIENTS_EXPERIENCE/elchin_mukhtar... | Civil society: practical role in improving TB outcomes and supporting patients and programs by Elchin Mukhtarli, “Saglamliga Khi... |
/documents/en/5_IMPROVING_PATIENTS_EXPERIENCE/ekaterine_sani... | Dr Eka Sanikidze, Director of TB patient Union, Georgia |
/documents/en/5_IMPROVING_PATIENTS_EXPERIENCE/patient_associ... | Patient association groups: what role in DRTB treatment programs? By Zamirbek Boronbaev & Kholdaraly Zakbarov, TB patient assoc... |
/documents/en/6_IMPROVING_PATIENTS_EXPERIENCE/gulzira_nurull... | Ambulatory treatment from day 1 by Dr Gulzira Nurullaeva, Medical Doctor, Médecins Sans Frontières, Uzbekistan |
/documents/en/6_IMPROVING_PATIENTS_EXPERIENCE/hakob_atchemya... | Ambulatory care: how to adapt treatment delivery at home by Dr Hakob Atchemyan, Research assistant, Médecins Sans Frontières, A... |
/documents/en/6_IMPROVING_PATIENTS_EXPERIENCE/saghit_bektaso... | Other approaches to patient delivery models by Dr Saghit Bektasov, Head of Medical Department, National Center for Tuberculosis,... |
/documents/en/6_IMPROVING_PATIENTS_EXPERIENCE/naira_khachatr... | Delivery methods for new drugs : Video DOT by Dr Naira Khachatryan, Deputy medical coordinator, Médecins Sans Frontières, Armeni... |
/documents/en/7_DIAGNOSTICS_AND_MONITORING/svetlana_setkina_... | How will pharmacovigilance (PV) help us manage our patients? By Dr Svetlana Setkina, Deputy Head of Republican Pharmacological L... |
/documents/en/7_DIAGNOSTICS_AND_MONITORING/nino_lomtadze_ads... | How will pharmacovigilance (PV) help us manage our patients? By Dr Nino Lomtadze, Head of surveillance and strategic planning de... |
/documents/en/7_DIAGNOSTICS_AND_MONITORING/elisa_ardizzoni_d... | DST to new drugs, early detection of eligible patients - Elisa Ardizzoni , Mycobacteriologist at Mycobacteriology Unit of Instit... |
/documents/en/7_DIAGNOSTICS_AND_MONITORING/animesh_sinha_dia... | Monitoring of comorbidities: the example of diabetes - Dr Animesh Sinha, Medical Activity Manager, Médecins Sans Frontières, Ope... |
/documents/en/participants_list.pdf | Participants List in English |
tb-symposium.org/2015/ | New treatments and approaches to Tuberculosis |
msf-tb-symposium.org/en/ | TB Symposium in Dushanbe, Tajikistan |
Domain Name: TB-SYMPOSIUM.ORG
Registry Domain ID: D175078620-LROR
Registrar WHOIS Server: whois.gandi.net
Registrar URL: http://www.gandi.net
Updated Date: 2017-12-21T10:07:00Z
Creation Date: 2015-01-21T11:55:28Z
Registry Expiry Date: 2019-01-21T11:55:28Z
Registrar Registration Expiration Date:
Registrar: Gandi SAS
Registrar IANA ID: 81
Registrar Abuse Contact Email: abuse@support.gandi.net
Registrar Abuse Contact Phone: +33.170377661
Reseller:
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Registry Registrant ID: C84153483-LROR
Registrant Name: Tanguy IMBERT
Registrant Organization: MAdecins Sans FrontiAres
Registrant Street: Obfuscated whois Gandi-63-65 boulevard Massena
Registrant City: Obfuscated whois Gandi-Paris
Registrant State/Province: Paris
Registrant Postal Code: 75013
Registrant Country: FR
Registrant Phone: +33.170377666
Registrant Phone Ext:
Registrant Fax: +33.143730576
Registrant Fax Ext:
Registrant Email: 186e183d4ed45193248f61a20f4b2c64-1061199@contact.gandi.net
Registry Admin ID: C84153483-LROR
Admin Name: Tanguy IMBERT
Admin Organization: MAdecins Sans FrontiAres
Admin Street: Obfuscated whois Gandi-63-65 boulevard Massena
Admin City: Obfuscated whois Gandi-Paris
Admin State/Province: Paris
Admin Postal Code: 75013
Admin Country: FR
Admin Phone: +33.170377666
Admin Phone Ext:
Admin Fax: +33.143730576
Admin Fax Ext:
Admin Email: 186e183d4ed45193248f61a20f4b2c64-1061199@contact.gandi.net
Registry Tech ID: C84153483-LROR
Tech Name: Tanguy IMBERT
Tech Organization: MAdecins Sans FrontiAres
Tech Street: Obfuscated whois Gandi-63-65 boulevard Massena
Tech City: Obfuscated whois Gandi-Paris
Tech State/Province: Paris
Tech Postal Code: 75013
Tech Country: FR
Tech Phone: +33.170377666
Tech Phone Ext:
Tech Fax: +33.143730576
Tech Fax Ext:
Tech Email: 186e183d4ed45193248f61a20f4b2c64-1061199@contact.gandi.net
Name Server: C.DNS.GANDI.NET
Name Server: B.DNS.GANDI.NET
Name Server: A.DNS.GANDI.NET
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of WHOIS database: 2018-02-05T02:23:22Z <<<
For more information on Whois status codes, please visit https://icann.org/epp
Access to Public Interest Registry WHOIS information is provided to assist persons in determining the contents of a domain name registration record in the Public Interest Registry registry database. The data in this record is provided by Public Interest Registry for informational purposes only, and Public Interest Registry does not guarantee its accuracy. This service is intended only for query-based access. You agree that you will use this data only for lawful purposes and that, under no circumstances will you use this data to: (a) allow, enable, or otherwise support the transmission by e-mail, telephone, or facsimile of mass unsolicited, commercial advertising or solicitations to entities other than the data recipient's own existing customers; or (b) enable high volume, automated, electronic processes that send queries or data to the systems of Registry Operator, a Registrar, or Afilias except as reasonably necessary to register domain names or modify existing registrations. All rights reserved. Public Interest Registry reserves the right to modify these terms at any time. By submitting this query, you agree to abide by this policy.
Франция - 78.109.92.151
Claranet France
Claranet France
HTTP/1.1 200 OK
Server: nginx
Content-Type: text/html
Last-Modified: Mon, 25 Sep 2017 15:12:59 GMT
Vary: Accept-Encoding
ETag: "59c91cfb-7edd"
Accept-Ranges: bytes
Content-Length: 32477
Accept-Ranges: bytes
Date: Tue, 03 Dec 2019 14:58:12 GMT
X-Varnish: 1634466716
Age: 0
Via: 1.1 varnish
Connection: keep-alive
X-Cache: MISS
Кнопка для анализа сайта в один клик, для установки перетащите ссылку на "Панель закладок"